Article
Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases.
Radiology and oncology - 7 Mar 2020
Goricar Katja, Kovac Viljem, Dodic-Fikfak Metoda, Dolzan Vita, Franko Alenka
Abstract excerpt
Background Asbestos exposure is associated with increased risk of several diseases, including malignant mesothelioma (MM). Cell surface glycoprotein mesothelin is overexpressed in MM and serum soluble mesothelin-related peptides (SMRP) were already proposed as a diagnostic or prognostic biomarker in MM. However, interindividual variability in serum SMRP levels limits the clinical usefulness. Our primary objective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
